1,1-dichloroethene decreases expression ISO RGD:1552999 6480464 vinylidene chloride results in decreased expression of PPP1R9A mRNA CTD PMID:26682919 1,2-dichloroethane decreases expression ISO RGD:1552999 6480464 ethylene dichloride results in decreased expression of PPP1R9A mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1552999 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPP1R9A mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of PPP1R9A mRNA CTD PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PPP1R9A mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1350094 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of PPP1R9A mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1552999 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPP1R9A mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R9A mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 4-hydroxyphenyl retinamide decreases expression ISO RGD:1552999 6480464 Fenretinide results in decreased expression of PPP1R9A mRNA CTD PMID:28973697 5-(hydroxymethyl)cytosine multiple interactions ISO RGD:1552999 6480464 [bisphenol A results in decreased methylation of PPP1R9A intron] which results in decreased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 acrolein multiple interactions ISO RGD:1350094 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PPP1R9A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PPP1R9A mRNA CTD PMID:32699268 acrylamide decreases expression ISO RGD:1350094 6480464 Acrylamide results in decreased expression of PPP1R9A mRNA CTD PMID:32763439 Aflatoxin B2 alpha increases methylation ISO RGD:1350094 6480464 aflatoxin B2 results in increased methylation of PPP1R9A intron CTD PMID:30157460 alpha-pinene multiple interactions ISO RGD:1350094 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PPP1R9A mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of PPP1R9A mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPP1R9A mRNA CTD PMID:16483693 antirheumatic drug increases expression ISO RGD:1350094 6480464 Antirheumatic Agents results in increased expression of PPP1R9A mRNA CTD PMID:24449571 aristolochic acid decreases expression ISO RGD:1350094 6480464 aristolochic acid I results in decreased expression of PPP1R9A mRNA CTD PMID:33212167 arsenous acid decreases expression ISO RGD:1350094 6480464 Arsenic Trioxide results in decreased expression of PPP1R9A mRNA CTD PMID:26705709 benzo[a]pyrene affects expression ISO RGD:1350094 6480464 Benzo(a)pyrene affects the expression of PPP1R9A mRNA CTD PMID:21714911 benzo[a]pyrene decreases methylation ISO RGD:1552999 6480464 Benzo(a)pyrene results in decreased methylation of PPP1R9A exon, Benzo(a)pyrene results in decreased methylation of PPP1R9A intron CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1350094 6480464 Benzo(a)pyrene affects the methylation of PPP1R9A 3' UTR, Benzo(a)pyrene affects the methylation of PPP1R9A promoter CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1350094 6480464 Benzo(a)pyrene results in increased methylation of PPP1R9A 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1350094 6480464 Benzo(a)pyrene results in decreased expression of PPP1R9A mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1350094 6480464 7 more ... CTD PMID:20018196 benzo[e]pyrene increases methylation ISO RGD:1350094 6480464 benzo(e)pyrene results in increased methylation of PPP1R9A intron CTD PMID:30157460 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPP1R9A mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO RGD:1552999 6480464 [bisphenol A results in decreased methylation of PPP1R9A intron] which results in decreased abundance of 5-hydroxymethylcytosine CTD PMID:30044229 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPP1R9A mRNA CTD PMID:30816183 , PMID:34947998 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of PPP1R9A gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPP1R9A mRNA CTD PMID:29097150 Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of PPP1R9A protein CTD PMID:28903499 butanal decreases expression ISO RGD:1350094 6480464 butyraldehyde results in decreased expression of PPP1R9A mRNA CTD PMID:26079696 carbon nanotube decreases expression ISO RGD:1552999 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of PPP1R9A protein CTD PMID:34058248 choline multiple interactions ISO RGD:1552999 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R9A mRNA CTD PMID:20938992 cisplatin multiple interactions ISO RGD:1350094 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PPP1R9A mRNA CTD PMID:27392435 cisplatin decreases expression ISO RGD:1350094 6480464 Cisplatin results in decreased expression of PPP1R9A mRNA CTD PMID:27392435 cobalt dichloride decreases expression ISO RGD:1350094 6480464 cobaltous chloride results in decreased expression of PPP1R9A mRNA CTD PMID:19376846 cyclosporin A decreases expression ISO RGD:1350094 6480464 Cyclosporine results in decreased expression of PPP1R9A mRNA CTD PMID:25562108 diarsenic trioxide decreases expression ISO RGD:1350094 6480464 Arsenic Trioxide results in decreased expression of PPP1R9A mRNA CTD PMID:26705709 dioxygen multiple interactions ISO RGD:1552999 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R9A mRNA CTD PMID:30529165 dorsomorphin multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:1350094 6480464 Doxorubicin results in decreased expression of PPP1R9A mRNA CTD PMID:29803840 elemental selenium multiple interactions ISO RGD:1350094 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA CTD PMID:19244175 elemental selenium decreases expression ISO RGD:1350094 6480464 Selenium results in decreased expression of PPP1R9A mRNA CTD PMID:19244175 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PPP1R9A mRNA CTD PMID:29391264 entinostat decreases expression ISO RGD:1350094 6480464 entinostat results in decreased expression of PPP1R9A mRNA CTD PMID:26272509 , PMID:27188386 entinostat multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R9A mRNA CTD PMID:27188386 ethanol affects splicing ISO RGD:1552999 6480464 Ethanol affects the splicing of PPP1R9A mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1552999 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R9A mRNA CTD PMID:20938992 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of PPP1R9A mRNA CTD PMID:22061828 , PMID:33387578 hydralazine multiple interactions ISO RGD:1350094 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R9A mRNA CTD PMID:17183730 ivermectin decreases expression ISO RGD:1350094 6480464 Ivermectin results in decreased expression of PPP1R9A protein CTD PMID:32959892 L-methionine multiple interactions ISO RGD:1552999 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R9A mRNA CTD PMID:20938992 latrunculin B affects localization EXP 6480464 latrunculin B affects the localization of PPP1R9A protein CTD PMID:12052877 menadione affects expression ISO RGD:1350094 6480464 Vitamin K 3 affects the expression of PPP1R9A mRNA CTD PMID:20044591 methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of PPP1R9A mRNA CTD PMID:15644446 methapyrilene increases methylation ISO RGD:1350094 6480464 Methapyrilene results in increased methylation of PPP1R9A intron CTD PMID:30157460 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of PPP1R9A gene CTD PMID:23303685 methylmercury chloride decreases expression ISO RGD:1350094 6480464 methylmercuric chloride results in decreased expression of PPP1R9A mRNA CTD PMID:28001369 N-acetyl-beta-D-glucosamine decreases expression ISO RGD:1350094 6480464 Acetylglucosamine results in decreased expression of PPP1R9A mRNA CTD PMID:18047607 N-acetyl-D-glucosamine decreases expression ISO RGD:1350094 6480464 Acetylglucosamine results in decreased expression of PPP1R9A mRNA CTD PMID:18047607 N-nitrosodiethylamine multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of PPP1R9A protein CTD PMID:20935162 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PPP1R9A protein CTD PMID:20935162 nickel atom decreases expression ISO RGD:1350094 6480464 Nickel results in decreased expression of PPP1R9A mRNA CTD PMID:24768652 , PMID:25583101 ozone multiple interactions ISO RGD:1350094 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of PPP1R9A mRNA more ... CTD PMID:32699268 paclitaxel decreases expression ISO RGD:1350094 6480464 Paclitaxel results in decreased expression of PPP1R9A mRNA CTD PMID:15000894 panobinostat multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R9A mRNA CTD PMID:27188386 panobinostat decreases expression ISO RGD:1350094 6480464 panobinostat results in decreased expression of PPP1R9A mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1552999 6480464 Acetaminophen affects the expression of PPP1R9A mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PPP1R9A mRNA CTD PMID:33387578 phenobarbital multiple interactions EXP 6480464 [Phenobarbital co-treated with Diethylnitrosamine] results in increased expression of PPP1R9A protein CTD PMID:20935162 phenobarbital affects expression ISO RGD:1552999 6480464 Phenobarbital affects the expression of PPP1R9A mRNA CTD PMID:23091169 phenyl acetate affects hydrolysis ISO RGD:1350094 6480464 PPP1R9A 3' UTR SNP affects the hydrolysis of phenyl acetate CTD PMID:20839225 phenylmercury acetate decreases expression ISO RGD:1350094 6480464 Phenylmercuric Acetate results in decreased expression of PPP1R9A mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R9A mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:1350094 6480464 potassium chromate(VI) results in increased expression of PPP1R9A mRNA CTD PMID:22714537 quercetin decreases expression ISO RGD:1350094 6480464 Quercetin results in decreased expression of PPP1R9A mRNA CTD PMID:21632981 rotenone decreases expression ISO RGD:1552999 6480464 Rotenone results in decreased expression of PPP1R9A mRNA CTD PMID:23186747 SB 431542 multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom multiple interactions ISO RGD:1350094 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA CTD PMID:19244175 selenium atom decreases expression ISO RGD:1350094 6480464 Selenium results in decreased expression of PPP1R9A mRNA CTD PMID:19244175 sodium arsenate increases expression ISO RGD:1552999 6480464 sodium arsenate results in increased expression of PPP1R9A mRNA CTD PMID:21795629 sodium arsenite increases expression ISO RGD:1350094 6480464 sodium arsenite results in increased expression of PPP1R9A mRNA CTD PMID:22714537 sodium arsenite decreases methylation ISO RGD:1552999 6480464 sodium arsenite results in decreased methylation of PPP1R9A gene CTD PMID:32068019 sodium arsenite affects methylation ISO RGD:1350094 6480464 sodium arsenite affects the methylation of PPP1R9A gene CTD PMID:28589171 sulforaphane decreases expression ISO RGD:1552999 6480464 sulforaphane results in decreased expression of PPP1R9A mRNA CTD PMID:30529165 temozolomide increases expression ISO RGD:1350094 6480464 Temozolomide results in increased expression of PPP1R9A mRNA CTD PMID:31758290 testosterone enanthate affects expression ISO RGD:1350094 6480464 testosterone enanthate affects the expression of PPP1R9A mRNA CTD PMID:17440010 trichostatin A decreases expression ISO RGD:1350094 6480464 trichostatin A results in decreased expression of PPP1R9A mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1350094 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R9A mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO RGD:1552999 6480464 trimellitic anhydride results in decreased expression of PPP1R9A mRNA CTD PMID:19042947 valproic acid multiple interactions ISO RGD:1350094 6480464 [Hydralazine co-treated with Valproic Acid] results in increased expression of PPP1R9A mRNA more ... CTD PMID:17183730 , PMID:27188386 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of PPP1R9A mRNA CTD PMID:29427782 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PPP1R9A mRNA CTD PMID:29427782 valproic acid decreases expression ISO RGD:1350094 6480464 Valproic Acid results in decreased expression of PPP1R9A mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:1350094 6480464 Valproic Acid affects the expression of PPP1R9A mRNA CTD PMID:25979313 valproic acid decreases methylation ISO RGD:1350094 6480464 Valproic Acid results in decreased methylation of PPP1R9A gene CTD PMID:29154799 vitamin E multiple interactions ISO RGD:1350094 6480464 [Selenium co-treated with Vitamin E] results in decreased expression of PPP1R9A mRNA CTD PMID:19244175 vitamin E decreases expression ISO RGD:1350094 6480464 Vitamin E results in decreased expression of PPP1R9A mRNA CTD PMID:19244175